RedHill Biopharma reported $214K in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Cara Therapeutics USD 0 0 Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 3.02M 91K Jun/2026
Cronos Group USD 1.3M 16K Jun/2026
RedHill Biopharma USD 214K 142K Jun/2025